DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP SOLUTION

Country: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

DEXAMETHASONE PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE)

থেকে পাওয়া:

STRIDES PHARMA CANADA INC

এটিসি কোড:

H02AB02

INN (International Name):

DEXAMETHASONE

ডোজ:

10MG

ফার্মাসিউটিকাল ফর্ম:

SOLUTION

রচনা:

DEXAMETHASONE PHOSPHATE (DEXAMETHASONE SODIUM PHOSPHATE) 10MG

প্রশাসন রুট:

INTRAMUSCULAR

প্যাকেজ ইউনিট:

10ML

প্রেসক্রিপশন টাইপ:

Prescription

Therapeutic area:

ADRENALS

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0106305005; AHFS:

অনুমোদন অবস্থা:

APPROVED

অনুমোদন তারিখ:

2020-07-30

পণ্য বৈশিষ্ট্য

1
PRESCRIBING INFORMATION
PR
DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP
4 MG/ML
STERILE SOLUTION FOR INTRAVENOUS, INTRAMUSCULAR, INTRA-ARTICULAR,
INTRALESIONAL, AND
SOFT TISSUE INJECTION
10 MG/ML STERILE SOLUTION FOR INTRAVENOUS, INTRAMUSCULAR
CORTICOSTEROID
Strides Pharma Canada Inc.
Date of revision
1565, Boul. Lionel-Boulet
July 30, 2020
Varennes, Quebec
J3X 1P7
Submission Control No.: 240776
2
PR
DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP
4 MG/ML
STERILE SOLUTION FOR INTRAVENOUS, INTRAMUSCULAR, INTRA-ARTICULAR,
INTRALESIONAL, AND
SOFT TISSUE INJECTION
10 MG/ML STERILE SOLUTION FOR INTRAVENOUS, INTRAMUSCULAR
CORTICOSTEROID
INDICATIONS
Dexamethasone Sodium Phosphate Injection may be given by I.V. or I.M.
injection when oral
therapy is not feasible in the following conditions:
ENDOCRINE DISORDERS: Primary or secondary adrenocortical insufficiency
(hydrocortisone or
cortisone
is
the
drug
of
choice;
synthetic
analogs
may
be
used
in
conjunction
with
mineralocorticoid
where
applicable;
in
infancy,
mineralocorticoid
supplementation
is
of
particular importance). Acute adrenocortical insufficiency
(hydrocortisone or cortisone is the
drug of choice; mineralocorticoid supplementation may be necessary,
particularly when synthetic
analogs are used). Preoperatively and in the event of serious trauma
or illness, in patients with
known adrenal insufficiency or when adrenocortical reserve is
doubtful.
Congenital adrenal hyperplasia.
Nonsupportive thyroiditis.
SHOCK: The adjunctive treatment of shock where high (pharmacologic)
doses of corticosteroids
are needed: e.g., severe shock of hemorrhagic, traumatic, surgical, or
septic origin. Treatment
with Dexamethasone Sodium Phosphate Injection is an adjunct to, and
not a substitute for,
specific or supportive measures that the patient may require, e.g.,
restoration of circulating blood
volume, correction of fluid and electrolyte balance, oxygen, surgical
measures and antibiotics.
RHEUMATIC DISORDERS: As adjunctive therapy for short-term
administration (to support the
patient